These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 10469062

  • 21. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 22. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
    Tang S, Xiao H, Fan Y, Wu F, Zhang Z, Li H, Yang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
    [Abstract] [Full Text] [Related]

  • 23. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.
    Kakumu S, Okumura A, Ishikawa T, Yano M, Enomoto A, Nishimura H, Yoshioka K, Yoshika Y.
    Clin Exp Immunol; 1997 Sep; 109(3):458-63. PubMed ID: 9328122
    [Abstract] [Full Text] [Related]

  • 24. Enhanced expression and shedding of tumor necrosis factor (TNF) receptors from mononuclear leukocytes in human heart failure.
    Nozaki N, Yamaguchi S, Yamaoka M, Okuyama M, Nakamura H, Tomoike H.
    J Mol Cell Cardiol; 1998 Oct; 30(10):2003-12. PubMed ID: 9799654
    [Abstract] [Full Text] [Related]

  • 25. An analysis of acute changes in interleukin-6 levels after treatment of hepatitis C with consensus interferon.
    Cotler SJ, Reddy KR, McCone J, Wolfe DL, Liu A, Craft TR, Ferris MW, Conrad AJ, Albrecht J, Morrissey M, Ganger DR, Rosenblate H, Blatt LM, Jensen DM, Taylor MW.
    J Interferon Cytokine Res; 2001 Dec; 21(12):1011-9. PubMed ID: 11798458
    [Abstract] [Full Text] [Related]

  • 26. [Soluble cytokinin receptors in renal vasculitis and lupus nephritis].
    Tesar V, Jirsa M, Masek Z, Bartůnková J, Stejskalová A, Dostál C, Zabka J, Chábová V, Rysavá R.
    Cas Lek Cesk; 1998 May 04; 137(9):271-5. PubMed ID: 9650355
    [Abstract] [Full Text] [Related]

  • 27. Plasma cytokine parameters and mortality in patients with chronic heart failure.
    Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJ, Anker SD.
    Circulation; 2000 Dec 19; 102(25):3060-7. PubMed ID: 11120695
    [Abstract] [Full Text] [Related]

  • 28. The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.
    Loppnow H, Werdan K, Werner C.
    Auton Autacoid Pharmacol; 2002 Apr 19; 22(2):83-92. PubMed ID: 12568125
    [Abstract] [Full Text] [Related]

  • 29. Increased soluble tumor necrosis factor receptor levels in the serum of elderly people.
    Hasegawa Y, Sawada M, Ozaki N, Inagaki T, Suzumura A.
    Gerontology; 2000 Apr 19; 46(4):185-8. PubMed ID: 10859456
    [Abstract] [Full Text] [Related]

  • 30. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
    Majewski S, Wojas-Pelc A, Malejczyk M, Szymanska E, Jablonska S.
    Acta Derm Venereol; 1999 May 19; 79(3):207-10. PubMed ID: 10384918
    [Abstract] [Full Text] [Related]

  • 31. Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
    Landmann R, Keilholz U, Scheibenbogen C, Brockhaus M, Gallati H, Denz H, Bargetzi M, Ludwig C.
    Cancer Immunol Immunother; 1994 Feb 19; 38(2):113-8. PubMed ID: 8306366
    [Abstract] [Full Text] [Related]

  • 32. Increased serum soluble tumor necrosis factor receptor levels are associated with insulin resistance in liver cirrhosis.
    Lin SY, Wang YY, Sheu WH.
    Metabolism; 2004 Jul 19; 53(7):922-6. PubMed ID: 15254888
    [Abstract] [Full Text] [Related]

  • 33. Cytokines, cytokine antagonists and soluble adhesion molecules in patients with ocular Behçet's disease treated with human recombinant interferon-alpha2a. Results of an open study and review of the literature.
    Kötter I, Koch S, Vonthein R, Rückwaldt U, Amberger M, Günaydin I, Zierhut M, Stübiger N.
    Clin Exp Rheumatol; 2005 Jul 19; 23(4 Suppl 38):S20-6. PubMed ID: 16273760
    [Abstract] [Full Text] [Related]

  • 34. Plasma concentrations of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in patients with anorexia nervosa.
    Nakai Y, Hamagaki S, Takagi R, Taniguchi A, Kurimoto F.
    J Clin Endocrinol Metab; 1999 Apr 19; 84(4):1226-8. PubMed ID: 10199758
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection.
    Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U.
    J Pediatr; 1996 Oct 19; 129(4):574-80. PubMed ID: 8859265
    [Abstract] [Full Text] [Related]

  • 36. Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight.
    Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF.
    J Allergy Clin Immunol; 2001 Jan 19; 107(1):165-70. PubMed ID: 11150007
    [Abstract] [Full Text] [Related]

  • 37. PEGylated recombinant human soluble tumour necrosis factor receptor type I (r-Hu-sTNF-RI): novel high affinity TNF receptor designed for chronic inflammatory diseases.
    Edwards CK.
    Ann Rheum Dis; 1999 Nov 19; 58 Suppl 1(Suppl 1):I73-81. PubMed ID: 10577978
    [Abstract] [Full Text] [Related]

  • 38. Plasma tumor necrosis factor-alpha, its soluble receptors and interleukin-1beta levels in critically burned patients.
    Zhang B, Huang YH, Chen Y, Yang Y, Hao ZL, Xie SL.
    Burns; 1998 Nov 19; 24(7):599-603. PubMed ID: 9882056
    [Abstract] [Full Text] [Related]

  • 39. Early detection of increased tumour necrosis factor alpha (TNFalpha) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course.
    Spielmann S, Kerner T, Ahlers O, Keh D, Gerlach M, Gerlach H.
    Acta Anaesthesiol Scand; 2001 Mar 19; 45(3):364-70. PubMed ID: 11207475
    [Abstract] [Full Text] [Related]

  • 40. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
    Tsao TC, Hong Jh, Li LF, Hsieh MJ, Liao SK, Chang KS.
    Chest; 2000 Jan 19; 117(1):103-9. PubMed ID: 10631206
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.